NASDAQ

Keryx Biopharmaceuticals Announces First Quarter 2016 Financial Results

Company reported $6.8 million in first quarter total revenues, including $5.6 million of Auryxia™ ...

Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2016 Financial Results

MORRIS PLAINS, N.J., April 28, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced ...

Summit Announces Further US Patent Granted for CDI Antibiotic Ridinilazole

OXFORD, United Kingdom, April 28, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), ...

NeuroVive’s R&D Team to Present Research Progress at Mitochondrial Medicine Conference

NeuroVive Pharmaceutical AB (publ), the pioneers in mitochondrial medicine, will present important research findings ...

INNATE PHARMA : UPCOMING INVESTOR CONFERENCES

MARSEILLE, France, April 28, 2016 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - ...

ADMA Biologics Announces Proposed Public Offering of Common Stock

RAMSEY, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage ...